Jpmorgan Chase & CO Clear Point Neuro, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 24,209 shares of CLPT stock, worth $619,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,209

Previous 548 4317.7%

Holding current value

$619,750

Previous $8,000 3487.5%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$11.89 - $18.8 $281,329 - $444,826	23,661 Added 4317.7%	24,209 $287,000
Q4 2024 Feb 12, 2025	SELL	$10.74 - $16.68 $99,044 - $153,822	-9,222 Reduced 94.39%	548 $8,000
Q3 2024 Dec 26, 2024	BUY	$5.3 - $13.18 $19,143 - $47,606	3,612 Added 58.66%	9,770 $109,000
Q3 2024 Nov 08, 2024	BUY	$5.3 - $13.18 $19,143 - $47,606	3,612 Added 58.66%	9,770 $109,000
Q2 2024 Dec 26, 2024	SELL	$5.25 - $6.73 $18,963 - $24,308	-3,612 Reduced 36.97%	6,158 $33,000
Q2 2024 Aug 12, 2024	SELL	$5.25 - $6.73 $50,893 - $65,240	-9,694 Reduced 61.15%	6,158 $33,000
Q1 2024 Dec 26, 2024	BUY	$6.03 - $7.86 $36,674 - $47,804	6,082 Added 62.25%	15,852 $107,000
Q1 2024 May 10, 2024	SELL	$6.03 - $7.86 $93,887 - $122,380	-15,570 Reduced 49.55%	15,852 $107,000
Q4 2023 Dec 26, 2024	BUY	$4.46 - $7.07 $96,567 - $153,079	21,652 Added 221.62%	31,422 $213,000
Q4 2023 Feb 12, 2024	SELL	$4.46 - $7.07 $46,303 - $73,400	-10,382 Reduced 24.83%	31,422 $213,000
Q3 2023 Nov 14, 2023	SELL	$5.01 - $7.09 $43,937 - $62,179	-8,770 Reduced 17.34%	41,804 $209,000
Q2 2023 Aug 11, 2023	BUY	$6.54 - $10.58 $93,888 - $151,886	14,356 Added 39.64%	50,574 $366,000
Q1 2023 May 11, 2023	BUY	$7.33 - $10.63 $12,600 - $18,272	1,719 Added 4.98%	36,218 $305,000
Q4 2022 Feb 13, 2023	BUY	$7.7 - $11.21 $13,036 - $18,978	1,693 Added 5.16%	34,499 $292,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $16.49 $6,854 - $11,510	-698 Reduced 2.08%	32,806 $340,000
Q2 2022 Aug 11, 2022	SELL	$7.09 - $13.65 $169,131 - $325,620	-23,855 Reduced 41.59%	33,504 $437,000
Q1 2022 May 11, 2022	BUY	$7.8 - $11.6 $36,862 - $54,821	4,726 Added 8.98%	57,359 $597,000
Q4 2021 Feb 10, 2022	BUY	$11.08 - $18.86 $15,656 - $26,649	1,413 Added 2.76%	52,633 $590,000
Q3 2021 Nov 12, 2021	BUY	$16.58 - $22.25 $849,227 - $1.14 Million	51,220 New	51,220 $910,000

Others Institutions Holding CLPT

# of Institutions

102

Shares Held

7.91M

Call Options Held

116K

Put Options Held

46.8K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $627M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Clear Point Neuro, Inc. Transaction History